Timed and targeted therapy for acute kidney injury: A glimpse of the future

Kidney International

Volumn 77, Issue 11, 2012, Pages 947-949

  Mehta, Ravindra L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; CREATININE; DIURETIC AGENT; DOPAMINE; ERYTHROPOIETIN; FENOLDOPAM; GAMMA GLUTAMYLTRANSFERASE; GROWTH FACTOR; PLACEBO; ANTIANEMIC AGENT;

ACUTE KIDNEY FAILURE; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HUMAN; INTENSIVE CARE UNIT; MORTALITY; PRIORITY JOURNAL; REVIEW; ACUTE DISEASE; BLOOD; DRUG ADMINISTRATION; EMERGENCY HEALTH SERVICE; KIDNEY DISEASE; METABOLISM; NOTE; PATIENT SELECTION; PREDICTION AND FORECASTING; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; URINE;

ACUTE DISEASE; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CREATININE; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; GAMMA-GLUTAMYLTRANSFERASE; HEMATINICS; HUMANS; INTENSIVE CARE UNITS; KIDNEY DISEASES; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TRIAGE;

EID: 77955878102     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.79     Document Type: Note

References (12)

1. Mehta RL, Kellum JA, Shah SV e t al. Acute Kidney Injury Network: report of an initiative to improve out comes in acute kidney injury. C rit Care 2007; 1 1: R31.
2. Rosner MH. Urinary biomarkers for the detection of renal injury. A dv Clin Chem 2009; 4 9: 7 3-9 7.
3. Endre ZH, Walker RJ, Pickering JW e t al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010; 77: 1 020-1030.
4. Dieterle F, Marrer E, Suzuki E et al. Monitoring kidney safety in drug development: emerging technologies and their implications. Curr Opin Drug Discov Devel 2008; 1 1: 6 0-7 1.
5. Macedo E, Mehta RL. Prerenal failure: from old concepts to new paradigms. Curr Opin Crit Care 2009; 1 5: 4 67-4 73.
6. Pickering JW, Frampton CM, Endre ZH. Evaluation of trial outcomes in acute kidney injury by creatinine modeling. C lin J Am Soc Nephrol 2009; 4 : 1705-1715.
7. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 ; 8 : R 204-R 212.
8. Bagshaw SM, Uchino S, Cruz D e t al. A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol Dial Transplant 2009 ; 24 : 2739-2744.
9. Khosla N, Soroko SB, Chertow GM e t al. Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury. Clin J Am Soc Nephrol 2009; 4 : 1 914-1 919.
10. Bahlmann FH, Fliser D. Erythropoietin and renoprotection . C urr Opin Nephrol Hypertens 2009; 18 : 15-20.
11. Glaspy J. Hematology: ESAs to treat anemia-balancing the risks and benefits. Nat Rev Clin Oncol 2009; 6 : 5 00-5 02.
12. Vaidya VS, Ford GM, Waikar SS e t al. A rapid urine test for early detection of kidney injury. Kidney Int 2009; 7 6: 1 08-1 14.